FINANCIALS

RARE Ultragenyx Pharmaceutical Inc 1515673

Income Statement
Revenue	rare-20241231	560,230,000
Net Income	rare-20241231	-569,183,000
Profit Margin		-101.6%

Balance Sheet
Current Assets	817,123,000
Assets	1,503,456,000
Current Liabilities	344,153,000
Liabilities	1,248,159,000
Equity	255,297,000
Shares Out	92,165,000

Cash Flow Statement
Operating Cash Flow	-414,188,000
Investing Cash Flow	-17,768,000

Market Analysis
Market Cap	5,357,101,087
Price	39.51
BVPS	2.77
PB	14.25
EPS	-7.29
PS	2.39
FCF	-431,956,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view RARE documents filed with the SEC.

RARE Filings Clear

View A List of Tickers